You are required to be logged in to access the full website
Click here if you have forgotten your username or password
1 May 2026 - Australian pharmaceutical company Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) announced on Thursday that the marketing authorisation application (MAA) filed in Europe for TLX101-Px (O-(2-[18F] fluoroethyl)-L-tyrosine, 18F-FET),...
1 May 2026 - FDB (First Databank Inc), a provider of workflow-integrated drug knowledge for healthcare professionals, announced on Thursday the launch of its new gravimetric module, designed to help pharmacies improve the safety, accuracy, and effici...
1 May 2026 - Bioregenerative technology company FesariusTherapeutics Inc announced on Thursday the publication of its peer reviewed evidence of category leading speed of 'neodermis' formation, which it claims may have the potential to reduc...
1 May 2026 - Clinical-stage biotechnology company Bambusa Therapeutics Inc announced on Thursday the completion of patient enrolment in its randomised, double-blind, placebo-controlled Phase 1b/2a trial of BBT001 in patients with moderate-to-severe a...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe